Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Wednesday, August 21, 2024
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Biolinq raises $58M for wearable biosensor tech and more digital health fundings

April 4, 2024
in Health
Reading Time: 4 mins read
A A
Biolinq raises M for wearable biosensor tech and more digital health fundings
0
SHARES
ShareShareShareShareShare

Biolinq raises $58M for wearable biosensor tech and more digital health fundings

California-based Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it scored $58 million in financing.

Alpha Wave Ventures led the round, with participation from Niterra’s corporate venture capital fund, which is jointly operated with Pegasus Tech Ventures. 

Existing investors, including AXA IM Alts, Senvest Management, Features Capital, Aphelion Capital, RiverVest Venture Partners, and Taisho Pharmaceutical, also participated in the raise. 

Biolinq created a wearable patch that evaluates glucose levels and levels of activity. Using small electrochemical sensors, the patch measures glucose levels from the intradermal space beneath the surface of one’s skin. 

The company will use the funds to perform a clinical trial on its glucose sensor and for FDA submission.

“Our technology approach enables access to a coveted, metabolically active compartment of the skin for biosensing without the use of introducer needles or bleeding,” Rich Yang, CEO of Biolinq, said in a statement. “Over the past decade, our team has been pioneering a new biosensor platform designed to inform and inspire, with a mission to reach more people that are in need of simple solutions to improve metabolic health.”


EarliTech Diagnostics, a company creating diagnostic and therapeutic offerings for children with autism, secured $21.5 million in Series B funding led by Nexus NeuroTech Ventures and Venture Investors Health Fund. 

The Georgia-based company offers the EarliPoint Evaluation, a platform to help clinicians diagnose and assess children aged 16-to-30 months with autism. 

Kids watch a video on a tablet of social interactions. At the same time, a biomarker tracks the child’s focus, proxies clinician diagnosis, and assesses the level of function on characteristics such as verbal ability and non-verbal learning.

The company will use the funds to advance its technology,  further commercialize its product, and advance clinical research. 


Manifold, an AI-enabled clinical research platform, announced its launch with $15 million in Series A funding led by TQ Ventures. 

New investors SK Ventures and Calibrate Ventures participated in the round alongside Dr. Sachin H. Jain and existing investors TTCER Partners. 

READ ALSO

State of digital health investment, part 5: HTC Vive

Consensus raises $11.5M for AI research engine for scientific papers

The company offers an AI-powered platform for clinical research aimed at streamlining workflows and data management. It allows researchers to manage cohort studies and patient registries, administer observational study workflows and provide a patient portal with surveys, consent tracking and digital outreach.   


Employee benefits platform Beanstalk Benefits, built out of Redesign Health, announced its launch with $7.5 million in funding. 

The company provides employees with a platform that allows them to choose their everyday benefits, including health, well-being, and wealth services, instead of having their employer choose for them.  

The benefits include offerings for chronic condition management, parenting, personal finance, elder care, fertility and mental health services. Employers contract with Beanstalk to provide the varied benefits, not each individual company. 

“We’ve spent the last year investing in the platform itself. It was important to us to create an intuitive user experience since employees have never picked their own non-insurance benefits before and aren’t necessarily familiar with what’s out there. We think they’re going to be very excited to discover just how tailored they can make their portfolios with all of the benefits innovation that’s out there to meet their unique needs,” Matthew Sydney, Beanstalk Benefits CEO and cofounder, told MobiHealthNews in an email.  

“In terms of next steps, now that the platform is available to the broader market, we’ll be focused on onboarding employers and building out our customer service team. Employers can launch Beanstalk within days of signing on at any time of year, so we’ll be investing to further enhance just how easy it is to work with Beanstalk. We’ll also be continually vetting and adding new benefits solutions to our suite as we aim to create the most comprehensive resource possible under that one employer contract.”

Credit: Source link

ShareTweetSendSharePin
Previous Post

GloRilla evades Damian Lillard question after provocative posts

Next Post

ALS drug will be pulled from US market after study showed patients didn’t benefit

Related Posts

State of digital health investment, part 5: HTC Vive
Health

State of digital health investment, part 5: HTC Vive

August 20, 2024
Consensus raises .5M for AI research engine for scientific papers
Health

Consensus raises $11.5M for AI research engine for scientific papers

August 20, 2024
NASA, ISS National Lab announces solicitation for space health technology
Health

NASA, ISS National Lab announces solicitation for space health technology

August 19, 2024
Indonesian puskesmas enhancing community health response with genAI
Health

Indonesian puskesmas enhancing community health response with genAI

August 19, 2024
Reproductive health app Clue partners with Headspace
Health

Reproductive health app Clue partners with Headspace

August 17, 2024
Q&A: Google on creating the loss of pulse detection technology
Health

Q&A: Google on creating the loss of pulse detection technology

August 16, 2024
Next Post
ALS drug will be pulled from US market after study showed patients didn’t benefit

ALS drug will be pulled from US market after study showed patients didn't benefit

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

What’s likely to move the market in the next trading session

What’s likely to move the market in the next trading session

August 13, 2024
Brits snap up lower mortgages as BOE cut boosts market

Brits snap up lower mortgages as BOE cut boosts market

August 20, 2024
‘Survive until 2025’: ‘Survive until 2025’: The U.K. gaming industry fights for the future amid U.S. strikes

‘Survive until 2025’: ‘Survive until 2025’: The U.K. gaming industry fights for the future amid U.S. strikes

August 13, 2024
Teladoc Health stock drops amidst Q2 2024 earnings report

Teladoc Health stock drops amidst Q2 2024 earnings report

August 1, 2024
How kids from rich families learn about money

How kids from rich families learn about money

July 24, 2024
The best headphones for running in 2024

The best headphones for running in 2024

July 30, 2024
UK slams Elon Musk after billionaire comments on riots

UK slams Elon Musk after billionaire comments on riots

August 6, 2024

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • Ukraine carries out one of largest-ever drone attacks on Moscow
  • Yankees’ DJ LeMahieu in another rut as porous season continues
  • Volatility spike was a ‘huge overreaction,’ but more could be ahead, strategist says
  • The EU wants no corner of the digital sphere left untouched, warning X and AI could be next

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In